Related Experiment Video
Updated: Jul 6, 2026
Proteomic Profile of EPS-Urine through FASP Digestion and Data-Independent Analysis
Published on: May 8, 2021
Exploring the uremic toxins using proteomic technologies
Eric Schiffer1, Harald Mischak, Raymond C Vanholder
1Mosaiques Diagnostics & Therapeutics, Hanover, Germany.
Abstract:
Kidney failure leads to the uremic syndrome that is the clinical expression of the malfunction of vital organs due to the accumulation of uremic toxins, which are normally cleared by the kidneys. Progressively more uremic retention solutes have been identified and their potential toxicity has been characterized. Polypeptides constitute a heterogeneous group of uremic molecules. Therefore, proteome analysis represents a new and promising analytical approach to identify new uremic toxins. Proteomic technologies cover applicability to a broad molecular mass range. For polypeptides >10 kDa classical proteomic techniques, such as two-dimensional gel electrophoresis followed by mass spectrometry, are able to identify uremic polypeptides. In the mass range from approximately 1 to 10 kDa, capillary electrophoresis coupled to mass spectrometry (CE-MS) emerged as a fast possibility to analyze of up to 1,400 compounds in a single step. This chapter will provide an overview about proteomic technologies as efficient tools for the detection of uremic toxins, emphasizing the features of CE-MS. Subsequently, examples of the application of proteomic techniques to define novel biomarkers for renal diseases and uremic toxins will be discussed.
Insights
Proteomics, including capillary electrophoresis coupled to mass spectrometry (CE-MS), offers advanced methods for identifying uremic toxins. These novel biomarkers are crucial for understanding kidney failure and developing new diagnostics.
Area of Science:
- Biochemistry
- Nephrology
- Analytical Chemistry
Background:
- Kidney failure causes uremic syndrome due to the accumulation of toxic substances normally cleared by the kidneys.
- Polypeptides are a significant, heterogeneous group of these uremic toxins.
- Identifying and characterizing these toxins is vital for understanding disease progression.
Purpose of the Study:
- To provide an overview of proteomic technologies for detecting uremic toxins.
- To highlight the capabilities of capillary electrophoresis coupled to mass spectrometry (CE-MS) in this field.
- To discuss the application of proteomics in identifying novel biomarkers for renal diseases.
Main Methods:
- Proteomic analysis, including classical techniques like 2D gel electrophoresis and mass spectrometry for larger polypeptides (>10 kDa).
- Capillary electrophoresis coupled to mass spectrometry (CE-MS) for analyzing smaller polypeptides (1-10 kDa), capable of analyzing up to 1,400 compounds.
- Review of proteomic applications in biomarker discovery for renal diseases.
Main Results:
- Proteomic technologies are effective tools for detecting a wide range of uremic toxins.
- CE-MS is a rapid and powerful method for analyzing medium-sized polypeptides in uremic samples.
- Proteomic approaches have successfully identified novel biomarkers associated with renal diseases.
Conclusions:
- Proteomics offers promising avenues for identifying new uremic toxins and biomarkers.
- CE-MS is particularly valuable for the analysis of medium-sized polypeptides in uremic syndrome.
- These advancements in proteomic analysis are crucial for improving the diagnosis and understanding of kidney failure.
More Related Videos
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
10:37Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification
Published on: November 15, 2017
